AirSculpt Technologies, Inc. reported a significant decline in financial performance for the fiscal year ending December 31, 2025, with total revenue of $151.8 million, down approximately 15.8% from $180.4 million in 2024. The company also recorded a net loss of $11.7 million, compared to a loss of $8.0 million in the previous year. This downturn is attributed primarily to a decrease in the number of procedures performed, which fell to 11,852 from 14,036 in 2024, reflecting a broader decline in the aesthetics industry.
In response to these challenges, AirSculpt has implemented several strategic initiatives aimed at returning to revenue growth. These include optimizing marketing investments, enhancing sales strategies, expanding consumer financing options, and introducing new product innovations, particularly in skin tightening procedures. The company has also paused the opening of new centers to focus on improving liquidity and operational efficiency. As of March 31, 2026, AirSculpt operated 31 centers across 20 U.S. states and Canada, with plans for future expansion contingent on market conditions.
Operationally, the company reported a decrease in revenue per case, which was $12,809 in 2025, slightly down from $12,849 in 2024. The same-center revenue per case showed a marginal increase of 0.1%, while same-center volume experienced a decline of 22.1%. The company’s total operating expenses for 2025 were $163.4 million, leading to a loss from operations of $11.6 million. The decrease in operating expenses was primarily due to reduced advertising costs and other operational efficiencies.
AirSculpt's financial outlook remains cautious, with management emphasizing the need to stabilize performance and enhance marketing effectiveness. The company has also made efforts to strengthen its balance sheet, including a recent public offering that generated approximately $13.8 million in net proceeds, which were used to prepay a portion of its outstanding debt. As of December 31, 2025, AirSculpt had $8.4 million in cash and cash equivalents, alongside a revolving credit facility of $5.0 million available for use.
Looking ahead, AirSculpt aims to leverage its proprietary AirSculpt® method to differentiate itself in the competitive body contouring market, which is projected to grow significantly. However, the company faces challenges from increasing competition, particularly from non-surgical weight loss solutions and evolving consumer preferences. The management's ability to execute its growth strategies effectively will be critical in navigating these market dynamics and achieving long-term profitability.
About Airsculpt Technologies, Inc.
AirSculpt Technologies, Inc. specializes in minimally invasive body contouring procedures that remove fat and tighten skin without needles, scalpels, stitches, or general anesthesia. Its proprietary AirSculpt® method offers customized fat removal and fat transfer treatments, including the Power BBL®, Up a Cup™, and Hip Flip®. Serving primarily affluent metropolitan and suburban markets across the U.S., Canada, and the U.K., AirSculpt delivers premium patient experiences through surgeon-led care in spa-like centers, operating on a private-pay, scalable business model.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.